Deoxyhypusine hydroxylase from Plasmodium vivax, the neglected human malaria parasite: molecular cloning, expression and specific inhibition by the 5-LOX inhibitor zileuton.
Primaquine, an 8-aminoquinoline, is the only drug which cures the dormant hypnozoites of persistent liver stages from P. vivax. Increasing resistance needs the discovery of alternative pathways as drug targets to develop novel drug entities. Deoxyhypusine hydroxylase (DOHH) completes hypusine biosyn...
Main Authors: | Veronika Anyigoh Atemnkeng, Mario Pink, Simone Schmitz-Spanke, Xian-Jun Wu, Liang-Liang Dong, Kai-Hong Zhao, Caroline May, Stefan Laufer, Barbara Langer, Annette Kaiser |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3591309?pdf=render |
Similar Items
-
Cloning, expression and functional activity of deoxyhypusine synthase from <it>Plasmodium vivax</it>
by: Nassar Marwa, et al.
Published: (2006-10-01) -
Validation of Plasmodium falciparum deoxyhypusine synthase as an antimalarial target
by: Aiyada Aroonsri, et al.
Published: (2019-04-01) -
Why is Plasmodium vivax a neglected tropical disease?
by: Jane M Carlton, et al.
Published: (2011-06-01) -
Clinical proteomics of the neglected human malarial parasite Plasmodium vivax.
by: Pragyan Acharya, et al.
Published: (2011-01-01) -
A long neglected world malaria map: Plasmodium vivax endemicity in 2010.
by: Peter W Gething, et al.
Published: (2012-01-01)